Matches in SemOpenAlex for { <https://semopenalex.org/work/W4252248241> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4252248241 abstract "Abstract Background： The safety and efficiency of intravenous administration of tranexamic acid (TXA) in coronary artery bypass grafting (CABG) remains unconfirmed. Therefore, we conducted a meta-analysis on this topic. Methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PUBMED and EMBASE for randomized controlled trials on the topic. The results of this work are synthetized and reported in accordance with the PRISMA statement. Results： 28 studies met our inclusion criteria. TXA reduced the incidence of postoperative reoperation of bleeding (relative risk [RR], 0.46; 95% confidence interval [CI]; 0.31-0.68), the frequency of any allogeneic transfusion (RR, 0.64; 95% CI, 0.52-0.78) and the postoperative chest tube drainage in the first 24 hours by 206 ml (95% CI -248.23 to -164.15). TXA did not significantly affect the incidence of postoperative cerebrovascular accident (RR, 0.93; 95%CI, 0.62-1.39), mortality (RR, 0.82; 95%CI, 0.53–1.28), myocardial infarction (RR, 0.90; 95%CI, 0.78–1.05), acute renal insufficiency (RR, 1.01; 95%CI, 0.77–1.32). However, it may increase the incidence of postoperative seizures (RR, 6.67; 95%CI, 1.77–25.20). Moreover, the subgroup analyses in the settings of on-pump and off-pump CABG and the sensitivity analyses in trials randomized not less than 100 participants or with the maximum sample size study excluded further strengthened the above results. Conclusions: TXA is effective to reduce reoperation for bleeding, blood loss and the need for allogeneic blood products in patients undergoing CABG without increasing prothrombotic complication. However, it may increase the risk of postoperative seizures. Key words: Coronary Artery Bypass, Postoperative Complications, Tranexamic Acid" @default.
- W4252248241 created "2022-05-12" @default.
- W4252248241 creator A5005894428 @default.
- W4252248241 creator A5006139361 @default.
- W4252248241 creator A5031306882 @default.
- W4252248241 creator A5039849505 @default.
- W4252248241 creator A5048759917 @default.
- W4252248241 creator A5072882183 @default.
- W4252248241 creator A5083616520 @default.
- W4252248241 date "2018-12-13" @default.
- W4252248241 modified "2023-10-16" @default.
- W4252248241 title "The safety and efficiency of intravenous administration of tranexamic acid in coronary artery bypass grafting (CABG): A meta-analysis of 28 randomized controlled trials" @default.
- W4252248241 doi "https://doi.org/10.21203/rs.2.99/v1" @default.
- W4252248241 hasPublicationYear "2018" @default.
- W4252248241 type Work @default.
- W4252248241 citedByCount "0" @default.
- W4252248241 crossrefType "posted-content" @default.
- W4252248241 hasAuthorship W4252248241A5005894428 @default.
- W4252248241 hasAuthorship W4252248241A5006139361 @default.
- W4252248241 hasAuthorship W4252248241A5031306882 @default.
- W4252248241 hasAuthorship W4252248241A5039849505 @default.
- W4252248241 hasAuthorship W4252248241A5048759917 @default.
- W4252248241 hasAuthorship W4252248241A5072882183 @default.
- W4252248241 hasAuthorship W4252248241A5083616520 @default.
- W4252248241 hasBestOaLocation W42522482411 @default.
- W4252248241 hasConcept C120665830 @default.
- W4252248241 hasConcept C121332964 @default.
- W4252248241 hasConcept C126322002 @default.
- W4252248241 hasConcept C141071460 @default.
- W4252248241 hasConcept C168563851 @default.
- W4252248241 hasConcept C2779637338 @default.
- W4252248241 hasConcept C2991743468 @default.
- W4252248241 hasConcept C42219234 @default.
- W4252248241 hasConcept C44249647 @default.
- W4252248241 hasConcept C500558357 @default.
- W4252248241 hasConcept C61511704 @default.
- W4252248241 hasConcept C71924100 @default.
- W4252248241 hasConcept C82789193 @default.
- W4252248241 hasConcept C95190672 @default.
- W4252248241 hasConceptScore W4252248241C120665830 @default.
- W4252248241 hasConceptScore W4252248241C121332964 @default.
- W4252248241 hasConceptScore W4252248241C126322002 @default.
- W4252248241 hasConceptScore W4252248241C141071460 @default.
- W4252248241 hasConceptScore W4252248241C168563851 @default.
- W4252248241 hasConceptScore W4252248241C2779637338 @default.
- W4252248241 hasConceptScore W4252248241C2991743468 @default.
- W4252248241 hasConceptScore W4252248241C42219234 @default.
- W4252248241 hasConceptScore W4252248241C44249647 @default.
- W4252248241 hasConceptScore W4252248241C500558357 @default.
- W4252248241 hasConceptScore W4252248241C61511704 @default.
- W4252248241 hasConceptScore W4252248241C71924100 @default.
- W4252248241 hasConceptScore W4252248241C82789193 @default.
- W4252248241 hasConceptScore W4252248241C95190672 @default.
- W4252248241 hasLocation W42522482411 @default.
- W4252248241 hasLocation W42522482412 @default.
- W4252248241 hasLocation W42522482413 @default.
- W4252248241 hasOpenAccess W4252248241 @default.
- W4252248241 hasPrimaryLocation W42522482411 @default.
- W4252248241 hasRelatedWork W1967924121 @default.
- W4252248241 hasRelatedWork W1994906722 @default.
- W4252248241 hasRelatedWork W2022205929 @default.
- W4252248241 hasRelatedWork W2160599911 @default.
- W4252248241 hasRelatedWork W2235155022 @default.
- W4252248241 hasRelatedWork W2323811014 @default.
- W4252248241 hasRelatedWork W2886454030 @default.
- W4252248241 hasRelatedWork W3005740510 @default.
- W4252248241 hasRelatedWork W3030276453 @default.
- W4252248241 hasRelatedWork W3212844877 @default.
- W4252248241 isParatext "false" @default.
- W4252248241 isRetracted "false" @default.
- W4252248241 workType "article" @default.